ທ່ານດຣ Edwin P. Alyea

ທ່ານດຣ Edwin P. Alyea ຊ່ຽວຊານໃນການປິ່ນປົວຄົນເຈັບທີ່ເປັນມະເຮັງໃນເລືອດທີ່ກໍາລັງພິຈາລະນາການປ່ຽນຈຸລັງລໍາຕົ້ນ ຫຼື ໄຂກະດູກ. ໃນໄລຍະ 20 ປີຜ່ານມາ, ການປູກຖ່າຍມີຄວາມຄືບໜ້າຢ່າງໃຫຍ່ຫຼວງ, ເຊິ່ງໄດ້ສົ່ງຜົນໃຫ້ຜົນໄດ້ຮັບທີ່ດີຂຶ້ນ. ຄວາມກ້າວຫນ້າເຫຼົ່ານີ້ລວມມີຄວາມສາມາດໃນການນໍາໃຊ້ປະລິມານຢາເຄມີບໍາບັດຕ່ໍາເພື່ອຫຼຸດຜ່ອນຄວາມເປັນພິດໃນຄົນເຈັບ, ເຊັ່ນດຽວກັນກັບວິທີການຫຼຸດຜ່ອນຄວາມເປັນໄປໄດ້ຂອງ relapse. ຂ້າພະເຈົ້າມີຄວາມສົນໃຈໃນການນໍາໃຊ້ຢາໃຫມ່ແລະເຕັກນິກການປັບປຸງຜົນໄດ້ຮັບຫຼັງຈາກການປູກຖ່າຍຈຸລັງລໍາຕົ້ນສໍາລັບໂຣກມະເຮັງໃນເລືອດ. ມັນເປັນສິ່ງ ສຳ ຄັນທີ່ຈະຮ່ວມມືກັບຄົນເຈັບເພື່ອ ກຳ ນົດເປົ້າ ໝາຍ ການປິ່ນປົວຂອງພວກເຂົາແລະການປະຕິບັດທີ່ດີທີ່ສຸດ. ເປັນ​ເວລາ​ຫຼາຍ​ປີ​ຫຼັງ​ການ​ປ່ຽນ​ຖ່າຍ​ຂອງ​ເຂົາ​ເຈົ້າ, ຂ້ອຍ​ມັກ​ເຮັດ​ວຽກ​ກັບ​ຄົນ​ເຈັບ​ແລະ​ຄອບຄົວ​ຂອງ​ເຂົາ​ເຈົ້າ.

ໃບຢັ້ງຢືນຄະນະ

ຄະ​ນະ​ກໍາ​ມະ​ການ​ແພດ​ພາຍ​ໃນ​ອາ​ເມລິ​ກາ, Oncology ການ​ແພດ

Fellowship

Medical Oncology, ສະຖາບັນມະເຮັງ Dana-Farber (ລັດ Massachusetts), 1992-1995

ທີ່ພັກອາໄສ

ການແພດພາຍໃນ, ໂຮງໝໍບຣິກຳ ແລະ ແມ່ຍິງ (ລັດ Massachusetts), 1989-1992

ການສຶກສາ

MD, ມະຫາວິທະຍາໄລ Duke, 1989

• ໄຂກະດູກຜູ້ໃຫຍ່ ແລະ ການປູກຖ່າຍຈຸລັງລໍາຕົ້ນ
• Autologous Transplant
• Allogeneic Transplant
• ການປູກຖ່າຍແບບ Syngeneic

• Hourigan, Christopher S., Laura W. Dillon, Gege Gui, Brent R. Logan, Mingwei Fei, Jack Ghannam, Yuesheng Li, et al. “Impact of Conditioning Intensity of Allogeneic Transplantation for Myeloid Leukemia Acute Myeloid With Genomic Evidence of Residual Disease.” J Clin Oncol 38, ບໍ່. 12 (20 ເມສາ 2020): 1273–83. https://doi.org/10.1200/JCO.19.03011.
• Soiffer, Robert J., Haesook T. Kim, Joseph McGuirk, Mitchell E. Horwitz, Laura Johnston, Mrinal M. Patnaik, Witold Rybka, et al. “Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.” J Clin Oncol 35, ບໍ່. 36 (ເດືອນທັນວາ 20, 2017): 4003–11. https://doi.org/10.1200/JCO.2017.75.8177.
• Liu, Hien Duong, Kwang Woo Ahn, Zhen-Huan Hu, Mehdi Hamadani, Taiga Nishihori, Baldeep Wirk, Amer Beitinjaneh, et al. “Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.” ການປູກຖ່າຍໄຂ່ຫຼັງໃນເລືອດ 23, ບໍ່. 5 (ພຶດສະພາ 2017): 767–75. https://doi.org/10.1016/j.bbmt.2017.01.078.
• Scott, Bart L., Marcelo C. Pasquini, Brent R. Logan, Juan Wu, Steven M. Devine, David L. Porter, Richard T. Maziarz, et al. “Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.” J Clin Oncol 35, ບໍ່. 11 (10 ເມສາ 2017): 1154–61. https://doi.org/10.1200/JCO.2016.70.7091.
• Shaffer, Brian C., Kwang Woo Ahn, Zhen-Huan Hu, Taiga Nishihori, Adriana K. Malone, David Valcárcel, Michael R. Grunwald, et al. “Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.” J Clin Oncol 34, ບໍ່. 16 (1 ມິຖຸນາ 2016): 1864–71. https://doi.org/10.1200/JCO.2015.65.0515.
• Devine, Steven M., Kouros Owzar, William Blum, Flora Mulkey, Richard M. Stone, Jack W. Hsu, Richard E. Champlin, et al. “Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502.” J Clin Oncol 33, ບໍ່. 35 (ເດືອນທັນວາ 10, 2015): 4167–75. https://doi.org/10.1200/JCO.2015.62.7273.
• Jacobson, Caron A., Lixian Sun, Haesook T. Kim, Sean M. McDonough, Carol G. Reynolds, Michael Schowalter, John Koreth, et al. “Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease.” ການປູກຖ່າຍໄຂ່ຫຼັງໃນເລືອດ 20, ບໍ່. 5 (ພຶດສະພາ 2014): 668–75. https://doi.org/10.1016/j.bbmt.2014.01.021.
• Cutler, Corey, Haesook T. Kim, Bhavjot Bindra, Stefanie Sarantopoulos, Vincent T. Ho, Yi-Bin Chen, Jacalyn Rosenblatt, et al. “Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial.” ເລືອດ 122, ບໍ່. 8 (22 ສິງຫາ 2013): 1510–17. https://doi.org/10.1182/blood-2013-04-495895.
• Porcheray, Fabrice, David B. Miklos, Blair H. Floyd, Stefanie Sarantopoulos, Roberto Bellucci, Robert J. Soiffer, Joseph H. Antin, Edwin P. Alyea, Jerome Ritz, and Emmanuel Zorn. “Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation.” Transplantation 92, ບໍ່. 3 (15 ສິງຫາ 2011): 359–65. https://doi.org/10.1097/TP.0b013e3182244cc3.